Members |
associationTargetComponent |
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 0.9 mL syringe (trade product unit of use) |
Unknown Cell Type 2 |
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL syringe (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL syringe (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL syringes (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL syringes (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 1 x 10 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 1 x 10 mL vial (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 10 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 4 x 10 mL vials (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 4 x 10 mL vials (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 1 x 20 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 1 x 20 mL vial (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 20 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 4 x 20 mL vials (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 4 x 20 mL vials (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 1 x 4 mL vial (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 1 x 4 mL vial (trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 4 mL vial (trade product unit of use) |
Unknown Cell Type 2 |
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 4 x 4 mL vials (containered trade product pack) |
Unknown Cell Type 2 |
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 4 x 4 mL vials (trade product pack) |
Unknown Cell Type 2 |
Actemra 162 mg/0.9 mL injection solution, 0.9 mL syringe |
Unknown Cell Type 2 |
Actemra 162 mg/0.9 mL injection solution, 0.9 mL syringe |
Unknown Cell Type 2 |
Actemra 162 mg/0.9 mL injection solution, 0.9 mL syringe |
Unknown Cell Type 2 |
Actemra 162 mg/0.9 mL injection solution, 4 x 0.9 mL syringes |
Unknown Cell Type 2 |
Actemra 162 mg/0.9 mL injection solution, 4 x 0.9 mL syringes |
Unknown Cell Type 2 |
Actemra 200 mg/10 mL concentrated injection, 10 mL vial |
Unknown Cell Type 2 |
Actemra 200 mg/10 mL concentrated injection, 10 mL vial |
Unknown Cell Type 2 |
Actemra 200 mg/10 mL concentrated injection, 10 mL vial |
Unknown Cell Type 2 |
Actemra 200 mg/10 mL concentrated injection, 4 x 10 mL vials |
Unknown Cell Type 2 |
Actemra 200 mg/10 mL concentrated injection, 4 x 10 mL vials |
Unknown Cell Type 2 |
Actemra 400 mg/20 mL concentrated injection, 20 mL vial |
Unknown Cell Type 2 |
Actemra 400 mg/20 mL concentrated injection, 20 mL vial |
Unknown Cell Type 2 |
Actemra 400 mg/20 mL concentrated injection, 20 mL vial |
Unknown Cell Type 2 |
Actemra 400 mg/20 mL concentrated injection, 4 x 20 mL vials |
Unknown Cell Type 2 |
Actemra 400 mg/20 mL concentrated injection, 4 x 20 mL vials |
Unknown Cell Type 2 |
Actemra 80 mg/4 mL concentrated injection, 4 mL vial |
Unknown Cell Type 2 |
Actemra 80 mg/4 mL concentrated injection, 4 mL vial |
Unknown Cell Type 2 |
Actemra 80 mg/4 mL concentrated injection, 4 mL vial |
Unknown Cell Type 2 |
Actemra 80 mg/4 mL concentrated injection, 4 x 4 mL vials |
Unknown Cell Type 2 |
Actemra 80 mg/4 mL concentrated injection, 4 x 4 mL vials |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 0.9 mL injection device (trade product unit of use) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL injection device (containered trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL injection device (trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL injection devices (containered trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL injection devices (trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 0.9 mL injection device (trade product unit of use) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 1 x 0.9 mL injection device (containered trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 1 x 0.9 mL injection device (trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL injection devices (containered trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL injection devices (trade product pack) |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection solution, 0.9 mL injection device |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection solution, 0.9 mL injection device |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection solution, 0.9 mL injection device |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection solution, 4 x 0.9 mL injection devices |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection solution, 4 x 0.9 mL injection devices |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection, 0.9 mL injection device |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection, 0.9 mL injection device |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection, 0.9 mL injection device |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices |
Unknown Cell Type 2 |
Actemra Actpen 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 100 mL (trade product pack) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 100 mL, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 200 mL (trade product pack) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 200 mL, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 30 mL (trade product pack) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 30 mL, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 5 mL measure (trade product unit of use) |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 100 mL |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 100 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 200 mL |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 200 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 30 mL |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 30 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 5 mL measure |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 100 mL |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 100 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 200 mL |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 200 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 30 mL |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 30 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 5 mL |
Unknown Cell Type 2 |
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 1 mL measure (trade product unit of use) |
Unknown Cell Type 2 |
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 200 mL (trade product pack) |
Unknown Cell Type 2 |
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 200 mL, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 30 mL (trade product pack) |
Unknown Cell Type 2 |
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 30 mL, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Actifed CC Dry Cough 1 mg/mL oral liquid solution |
Unknown Cell Type 2 |
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 200 mL |
Unknown Cell Type 2 |
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 200 mL, bottle |
Unknown Cell Type 2 |
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 30 mL |
Unknown Cell Type 2 |
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 30 mL, bottle |
Unknown Cell Type 2 |
Actilax (lactulose 3.34 g / 5 mL) oral liquid solution, 5 mL measure (trade product unit of use) |
Unknown Cell Type 2 |
Actilax (lactulose 3.34 g / 5 mL) oral liquid solution, 500 mL (trade product pack) |
Unknown Cell Type 2 |
Actilax (lactulose 3.34 g / 5 mL) oral liquid solution, 500 mL, bottle (containered trade product pack) |
Unknown Cell Type 2 |
Actilax 3.34 g/5 mL oral liquid, 5 mL |
Actilax 3.3 g/5 mL oral liquid, 5 mL |
Actilax 3.34 g/5 mL oral liquid, 500 mL |
Actilax 3.3 g/5 mL oral liquid, 500 mL |
Actilax 3.34 g/5 mL oral liquid, 500 mL, bottle |
Actilax 3.3 g/5 mL oral liquid, 500 mL, bottle |
Actilax 3.34 g/5 mL oral liquid solution, 5 mL |
Unknown Cell Type 2 |
Actilax 3.34 g/5 mL oral liquid solution, 500 mL |
Unknown Cell Type 2 |
Actilax 3.34 g/5 mL oral liquid solution, 500 mL, bottle |
Unknown Cell Type 2 |
Actinobacillus actinomycetem comitans |
Aggregatibacter actinomycetemcomitans |